NeoTRACT: Phase II Trial of Neoadjuvant Tumor Infiltrating Lymphocyte- and Response-Adapted Chemoimmunotherapy for Triple-Negative Breast Cancer (TNBC).
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined